Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MariMed Hemp is a hemp-focused subsidiary associated with MariMed that was formed to develop, brand, distribute, and commercialize hemp-derived cannabinoid products in the United States. The business was originally launched around hemp-derived CBD products and later MariMed disclosed a separate hemp-derived THC operating unit, MMA Hemp Inc., to expand selected consumer brands into hemp channels. The entity appears to function primarily as a branded consumer cannabinoid products business rather than a traditional drug-development biotech company. Its activities are commercial, centered on formulation, branding, distribution, and retail expansion for wellness-oriented hemp products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MariMed Hemp.